viewEuropean Gas

European Gas granted new exploration permit in Northern France


Hydrocarbon producer and developer European Gas (ASX: EPG) has reported that the French Government has formally granted its wholly‐owned subsidiary Gazonor S.A. a new exploration permit “Sud Midi”, located in the Nord Pas de Calais region.

The “Sud Midi” permit increases EGL’s portfolio and confirms its position among the largest CBM and unconventional gas permit holders in Western Europe. EGL has a 100% working interest.

This exploration permit is adjacent to EGL’s Gazonor Production Concession, and, together with the Valenciennois Exploration Permit, forms a contiguous permit area of 1,352 km2.

The permit area covers 929 km² and is located in the Nord Pas de Calais region (North of France). The permit is granted for a five year term until July 23rd 2015 with a total expenditure commitment of €1.9 million.

Peter Cockcroft, CEO, said, “this is an exciting addition to our current exploration and production asset portfolio located in the largest coal basin in France."

"The Sud Midi permit is ideally located relative to EGL’s existing production facilities, thus any exploration success in the Sud Midi permit will be relatively easy to commercialise and bring on stream, selling into well established markets.”

European Gas is to exploring and developing unconventional oil and gas with a primary focus on Coal Bed Methane and Coal Mine Methane projects, in particular, in France where the company, with major holdings under licence, holds a significant competitive advantage.

The western European natural gas market is substantial with advanced infrastructure, including extensive pipeline networks and a free and open market. European Gas also holds hydrocarbon royalties in the Canning Basin of Western Australia.

Quick facts: European Gas

Price: - -

Market: ASX
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Tonix Pharmaceuticals CEO talks through recent pre-clinical and clinical...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) CEO Seth Lederman sat down with Proactive at the BIO CEO & investor Conference in New York. Lederman says the biopharma company had recently unveiled the pre-clinical results of TNX-801, its live virus horsepox vaccine that prevents...

1 hour, 39 minutes ago

2 min read